← SynDRA
TOLCAPONE
SynDRA canonical compound SYN0005279 — structure-anchored drug synonym record
| Clinical phase | Withdrawn |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | COMT |
| Mechanism of action | Catechol O methyltransferase inhibitor |
All known targets
- COMT
- TTR
- Abcb11
- Comt
- GPR35
- KLF10
Mechanisms of action (all sources)
- Catechol O methyltransferase inhibitor
- COMT INHIBITOR
- Catechol O-methyltransferase inhibitor
Drug classes
- Anti-Dyskinesia Agents
- Antiparkinson Agents
- Catechol O-Methyltransferase Inhibitors
- Central Nervous System Agents
- Enzyme Inhibitors
- Catechol-O-Methyltransferase Inhibitor
ATC classes
- N04B · DOPAMINERGIC AGENTS
Cross-references
Synonyms
- RO 40-7592
- tasmar
- Tolcapona
- RO-40-7592
- RO-407592
- Tasmar
- Roche brand of tolcapone
- Ro-40-7592
- Tasmar (TN)
- Tolcapone [USAN:INN]
- Tolcapone (JAN/USAN/INN)
- Methanone,(3,4-dihydroxy-5-nitrophenyl)(4-methylphenyl)
- (3,4-Dihydroxy-5-nitrophenyl)(4-methylphenyl)methanone
- (3,4-dihydroxy-5-nitrophenyl)-(4-methylphenyl)methanone
- 3,4-Dihydroxy-4'-methyl-5-nitrobenzophenone
- 3,4-dihydroxy-5'-methyl-5-nitrobenzophenone
- Ro 40 7592
- CIF6334OLY
- tolcapone (usp monograph)
- Methanone, (3,4-dihydroxy-5-nitrophenyl)(4-methylphenyl)-
- Ro 407592
- tolcapone (usp-rs)
- 5-(4-methylbenzoyl)-3-nitrobenzene-1,2-diol
- DTXCID903685
- 3,4-dihydroxy-5-nitro-4'-methylbenzophenone
- 4'-methyl-3,4-dihydroxy-5-nitrobenzophenone
- CHEBI:63630
- 5-((4-methylphenyl)carbonyl)-3-nitrobenzene-1,2-diol
- Tolcaponum
- 5-[(4-METHYLPHENYL)CARBONYL]-3-NITROBENZENE-1,2-DIOL
- Ro407592
- Methanone,(3,4-dihydroxy-5-nitrophenyl)(4-methylphenyl)-
- RefChem:57103
- 3,4 Dihydroxy 5' methyl 5 nitrobenzophenone
- N04BX01
- (3,4-dihydroxy-5-nitrophenyl)(p-tolyl)methanone
- MFCD00866569
- s4021
Reported adverse events
- Rhabdomyolysis
- Agitation
- Alopecia
- Arthritis
- Cataract
- Constipation
- Dizziness
- Dyskinesia
- Dyspepsia
- Dystonia
- Fall
- Fatigue
Look up TOLCAPONE in the interactive SynDRA portal →